1.Clinical comprehensive evaluation of five marketed thrombopoietin receptor agonists in China
Yunjin ZHANG ; Xiaorong WU ; Zhiyun HUANG ; Meiyan ZHANG ; Fan ZHANG ; Hongtao LIU
China Pharmacy 2026;37(2):142-148
OBJECTIVE To conduct a clinical comprehensive evaluation of five marketed thrombopoietin receptor agonists (TPO-RA) approved in China, providing quantitative evidence for drug selection and therapeutic decision-making in medical institutions. METHODS Relevant data on Romiplostim for injection, Eltrombopag olamine tablets, Herombopag olamine tablets, Avatrombopag maleate tablets, and Lusutrombopag tablets were collected. Based on the Chinese Rapid Guide for Drug Evaluation and Selection in Medical Institutions (Second Edition), 12 formulations of these five TPO-RA were scored quantitatively and comparatively across five dimensions: pharmacological characteristics, efficacy, safety, cost-effectiveness, and other attributes. RESULTS The comprehensive scores of the 12 formulations ranged from 62.56 to 75.50 points, with most scoring ≥70 points. Using the highest-scoring formulation for each generic name as a representative, the overall rankings of the five TPO-RA were as follows: Lusutrombopag tablets (75.50 points), Eltrombopag olamine tablets (75.10 points), Avatrombopag maleate tablets (70.40 points), Romiplostim for injection (63.93 points), and Herombopag olamine tablets (63.52 points). Lusutrombopag tablets scored relatively high in pharmacological characteristics, safety, and cost-effectiveness, while Eltrombopag olamine tablets performed well in efficacy and cost-effectiveness. The other formulations showed varying scores across evaluation dimensions. CONCLUSIONS The five TPO-RA demonstrate favorable overall clinical value, with Lusutrombopag tablets and Eltrombopag olamine tablets ranking higher in comprehensive scores, these two drugs should be prioritized in drug selection and formula optimization by medical institutions.
2.Analysis of the impact factors and correlation of job embeddedness and turnover intention among pub-lic hospital medical staff
Fan YANG ; Zhiyun GAN ; Lingming ZHOU
Modern Hospital 2025;25(4):582-585,590
Objective To explore the current status and correlation between job embeddedness and turnover intention among healthcare workers in public hospitals in Guangzhou,providing empirical evidence for public hospital administrators to re-duce talent turnover.Methods This study surveyed 718 healthcare workers from 12 public tertiary hospitals in Guangzhou.Results The overall mean score for job embeddedness among healthcare workers was(3.78±0.84),and the overall mean score for turnover intention was(1.96±0.94).There was a significant negative correlation between job embeddedness and turn-over intention(r=-0.561,P<0.01),indicating that a higher level of job embeddedness corresponded to a lower turnover in-tention among healthcare workers.Additionally,factors such as age,marital status,number of children,monthly income,and years of work in the current hospital had significant effects on turnover intention.Conclusion The level of job embeddedness a-mong healthcare workers is moderate,and the turnover intention is relatively low,with a significant negative correlation between the two.In the context of high-quality development of public hospitals,the stability of medical talent is crucial,as excessive tal-ent turnover can increase costs and affect operational and service quality.Suggestions Hospital management should improve com-pensation and benefits,optimize salary structures,and increase benefit programs.They should also provide career development opportunities,establish a career development planning system,optimize the work environment,reasonably arrange work sched-ules,and provide good facilities.Furthermore,strengthening community connections,encouraging participation in community ac-tivities,and focusing on mental health by providing psychological counseling services are recommended.
3.Analysis of the impact factors and correlation of job embeddedness and turnover intention among pub-lic hospital medical staff
Fan YANG ; Zhiyun GAN ; Lingming ZHOU
Modern Hospital 2025;25(4):582-585,590
Objective To explore the current status and correlation between job embeddedness and turnover intention among healthcare workers in public hospitals in Guangzhou,providing empirical evidence for public hospital administrators to re-duce talent turnover.Methods This study surveyed 718 healthcare workers from 12 public tertiary hospitals in Guangzhou.Results The overall mean score for job embeddedness among healthcare workers was(3.78±0.84),and the overall mean score for turnover intention was(1.96±0.94).There was a significant negative correlation between job embeddedness and turn-over intention(r=-0.561,P<0.01),indicating that a higher level of job embeddedness corresponded to a lower turnover in-tention among healthcare workers.Additionally,factors such as age,marital status,number of children,monthly income,and years of work in the current hospital had significant effects on turnover intention.Conclusion The level of job embeddedness a-mong healthcare workers is moderate,and the turnover intention is relatively low,with a significant negative correlation between the two.In the context of high-quality development of public hospitals,the stability of medical talent is crucial,as excessive tal-ent turnover can increase costs and affect operational and service quality.Suggestions Hospital management should improve com-pensation and benefits,optimize salary structures,and increase benefit programs.They should also provide career development opportunities,establish a career development planning system,optimize the work environment,reasonably arrange work sched-ules,and provide good facilities.Furthermore,strengthening community connections,encouraging participation in community ac-tivities,and focusing on mental health by providing psychological counseling services are recommended.
4.Clinical efficacy of transcatheter tricuspid valve replacement in cardiac implantable electronic lead-related tricuspid regurgitation: A multi-center retrospective cohort study
Jingyi CAO ; Xiaoping NING ; Ning LI ; Fan QIAO ; Fan YANG ; Bailing LI ; Guangwei ZHOU ; Lin HAN ; Zhiyun XU ; Fanglin LU
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2024;31(06):818-825
Objective To analyze the clinical efficacy of transcatheter tricuspid valve replacement (TTVR) in cardiac implantable electronic lead-related tricuspid regurgitation (TR). Methods The patients with severe TR who underwent LuX-Valve TTVR in 9 Chinese medical centers from June 2020 to August 2021 were retrospectively enrolled. They were divided into a cardiac implantable electronic device (CIED) group and a non-CIED group based on whether they had pre-existing CIED implantation. Success of the procedure was defined as safe implantation of the LuX-Valve and complete withdrawal of the delivery system. Prognostic improvement was defined as a decrease of TR grade to≤2+ and an improvement of cardiac function by≥2 grades. Surgical success and postoperative prognosis were compared between the two groups. Results A total of 190 patients were collected, including 50 males and 140 females with a mean age of 66.2±7.8 years. There were 29 patients in the CIED group, and 161 patients in the non-CIED group. In the CIED group, 28 patients were implanted with a permanent pacemaker and 1 patient with a cardioverter-defibrillator. Preoperative New York Heart Association (NYHA) cardiac function class, TR degree, left ventricular ejection fraction, tricuspid annular plane systolic excusion, and cardiac risk scores were comparable between the two groups (P>0.05). Postoperative TR was reduced to≤2+ in all patients, and there was no statistical difference in the incidence of perivalvular leakage between the two groups (P=0.270). Postoperative CT of CIED patients showed the valve was in place, and the lead was not extruded, twisted, or deflected. The in-hospital mortality of the two groups were 10.3% and 1.9%, respectively, and the difference was statistically significant (P=0.047). In addition, there was no statistical difference between the two groups in terms of postoperative improvement of cardiac function and mortality in the 1- and 2-year follow-up. Conclusion TTVR is feasible, safe, and effective in patients with CIED implantation, and the pre-existing lead has no significant effect on the clinical efficacy.
5.Mechanical circulation support device as a bridging tool for heart transplantation recipients with refractory heart failure
Yangfeng TANG ; Jiajun ZHANG ; Bailing LI ; Jun WANG ; Xingli FAN ; Guangwei ZHOU ; Zhiyun XU ; Lin HAN
Chinese Journal of Organ Transplantation 2023;44(3):178-182
Objective:To explore the clinical outcomes of recipients with refractory heart failure requiring an insertion of mechanical circulation support(MCS)device prior to heart transplantation(HT).Methods:From March 2017 to December 2021, retrospective review is performed for clinical data of 7 recipients with refractory heart failure requiring a bridging placement of MCS.There are 2 males and 5 females with an average age of(39.0±16.3)years(7~56 years)and an average weight of(57.6±19.9)kg(7~56 kg).The primary diseases of recipients are dilated cardiomyopathy(4 cases)severe viral myocarditis(2 cases)and ischemic cardiomyopathy(1 case).All of them develope acute decompensation of congestive heart failure.Before implanting MCS, two or more inotropic drugs are offered at maximal doses ages or IABP device, 6 cases required cardio-pulmonary resuscitation treatment and another patient for Heartcon assistance.All the patients bridge to heart transplatation.Results:Adjuvant therapy of MCS was offered for(20.0±11.5)d(7~34 d).Emergency HT is performed.Two post-HT deaths occurr due to multiple organ failure(1 case)and severe infection(1 case).The remainders recover smoothly during a follow-up period of(6~24 months).Conclusions:MCS device is recommended as a bridging too for HT recipients with refractory heart failure.It is imperative to improve clinical outcomes with MCS support before an onset of multiple organ dysfunction.Despite a perioperative mortality, long-term prognosis is generally satisfactory.
6.Transcatheter tricuspid valve replacement via vena jugularis interna: A case report
Jingyi CAO ; Fan QIAO ; Zhigang SONG ; Qing XUE ; Chengliang CAI ; Fan YANG ; Guangwei ZHOU ; Bailing LI ; Jun WANG ; Lin HAN ; Zhiyun XU ; Fanglin LU
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2022;29(11):1540-1544
We reported a 54-year-old female patient with severe tricuspid regurgitation, who received mechanic valve in the mitral position 15 years ago. The patient’s Society of Thoracic Surgeons score was 8.27%, and was intolerant to open heart surgery, so she was recommended for transcatheter tricuspid valve replacement via right vena jugularis interna. The procedures were guided by echocardiography and X ray fluoroscopy on November 13, 2021, the prosthesis was implanted successfully, and the patient was recoved without any adverse events. After 1 month follow-up, her general condition was apparently improved.
7.Systematic review and Meta-analysis of the efficacy of Apatinib and Tegafur in the treatment of colonic neoplasms
Zhiyun HE ; Jie DANG ; Xiang CUI ; Zhengkui PENG ; Tianlong MA ; Jingchun FAN
International Journal of Surgery 2021;48(3):175-178,F4
Objective:To conduct a systematic review and Meta-analysis of the efficacy and safety of Apatinib and tegafur in colonic cancer.Methods:With "Apatinib" "Tegafur" "Colonic cancer" as keywords, PubMed, Embase, Web of Science, Cochrane Library, WanFang Data, VIP, CNKI and CBM were searched from inception to December 2020 to collect randomized controlled trail about treatment for colonic cancer with Apatinib and Tegafur. Evaluated the portion remission and stable duration and progression-free survival. Meta-analysis was performed by using RevMan 5.3 software.Results:Meta-analysis showed that in colonic cancer patients, the portion remission and stable duration, tumor progression of Apatinib were not inferior to those of Tegafur ( RR=1.10, 95% CI: 0.71-1.71, P=0.640; RR=0.51, 95% CI: 0.28-1.32, P=0.205). But for progression-free survival, Apatinib was superior to Tegafur in overall patients( SMD=0.90, 95% CI: 0.42-1.37, P<0.000 1). Conclusion:In the treatment of colon cancer, compared with Tegafur, Apatinib can effectively improve the progression-free survival and has better overall survival.
8.Surgical strategy for treatment of type A aortic dissection with small true lumen of the descending aorta
Yangfeng TANG ; Lin HAN ; Xingli FAN ; Boyao ZHANG ; Jiajun ZHANG ; Qing XUE ; Jie LU ; Zhiyun XU
Chinese Journal of Thoracic and Cardiovascular Surgery 2021;37(4):208-211
Objective:To summarize the results and methods of surgical treatment for type A aortic dissection with small true lumen of the descending aorta.Methods:9 patients underwent surgical treatment for type A aortic dissection with small true lumen of the descending aorta between January 2017 and December 2019 were analyzed retrospectively. There were 7 males and 2 females, mean age of (41.6±9.2) years. Acute dissection were 2 cases, and chronic dissection were 7 cases. Preoerative computed tomography was used to diagnose the dissection and evaluate the true lumen of the descending aorta. This procedure was done in all patients via a median sternotomy under hypothermic CPB with SCP. 4-branched prosthetic graft was used to replace the ascending aorta and aortic arch. The procedures involving the descending aorta: Hybrid surgery using TEVAR. Distal intimal flap fenestration. Implanting the intraoperative stent-graft or prosthetic graft at false lumen for second-step operation.Results:There was no in-hospital mortality. Stroke, Spinal cord, visceral ischemia and lower limbs malfunction were not observed. Reintervention was not found in case with acute dissection during follow-up. One patient who reveived fenestration underwent TEVAR, others with chronic dissection underwent thoracoabdominal aortic replacement 3 months after surgery.Conclusion:Hybrid or staged procedures was a suitable alternative to patients with type A aortic dissection with small true lumen of the descending aorta.
9. Surgical treatment strategy for endograft infection after thoracic endovascular aortic repair
Yangfeng TANG ; Lin HAN ; Xingli FAN ; Boyao ZHANG ; Jiajun ZHANG ; Qing XUE ; Zhiyun XU
Chinese Journal of Surgery 2019;57(11):848-852
Objective:
To examine the results of surgical treatment for endograft infection after thoracic endovascular aortic repair (TEAVR).
Methods:
Clinical data of 7 patients underwent surgical treatment for endograft infection after TEAVR at Department of Cardiothoracic Surgery, Changhai Hospital, the Navy Medical University between January 2016 and December 2018 were analyzed retrospectively. There were 6 males and 1 female, aging (51.5±16.7) years (range: 25 to 68 years). The origin of the aortic disease was descending aortic aneurysm in 5 cases, and Stanford B aortic dissection in 2 cases. Abdominal aorta below the level of the diaphragm was not involved in all patients. Two patients received "chimney technology" for left subclavian artery procedures. Time to infection was 5(3) months (
10.Surgical treatment strategy for endograft infection after thoracic endovascular aortic repair
Yangfeng TANG ; Lin HAN ; Xingli FAN ; Boyao ZHANG ; Jiajun ZHANG ; Qing XUE ; Zhiyun XU
Chinese Journal of Surgery 2019;57(11):848-852
Objective To examine the results of surgical treatment for endograft infection after thoracic endovascular aortic repair (TEAVR). Methods Clinical data of 7 patients underwent surgical treatment for endograft infection after TEAVR at Department of Cardiothoracic Surgery, Changhai Hospital, the Navy Medical University between January 2016 and December 2018 were analyzed retrospectively. There were 6 males and 1 female, aging (51.5±16.7) years (range: 25 to 68 years). The origin of the aortic disease was descending aortic aneurysm in 5 cases, and Stanford B aortic dissection in 2 cases. Abdominal aorta below the level of the diaphragm was not involved in all patients. Two patients received "chimney technology" for left subclavian artery procedures. Time to infection was 5(3) months (M(QR)) (range: 1 to 24 months). Aortic endograft infection was diagnosed with a combination of microbiology (positive blood cultures, except one with mycotic), radiological evidence and clinical evidence of sepsis. Two patients suffered from aorto‐esophageal fistula received emergency surgery, others were treated with elective surgery. Extra‐anatomic prosthetic graft bypass was used for reconstruction of aorta, infected endogarft and aorta was removed, sac drainage was performed. Aorto‐esophageal fistula was procedured according to the degree of lesions. All patients received antibiotics with specialist advice for 6 to 8 weeks. Results One patient died due to septic shock. In the follow‐time (range: 6 to 24 months), 1 patient suffered from thoracic infection in 3 months after surgery, an other patient got iliac abscess after a month. Conclusions Endograft infection after TEAVR is high risk but may be curative. Appropriate selection of patients for infected endograft explantation could get a satisfied results.

Result Analysis
Print
Save
E-mail